FDA 483 - Wuxi Biologics Co Ltd - June 04, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
WuXi Biologics, a drug substance and drug product manufacturer in Wuxi, Jiangsu, was cited for two observations during an FDA inspection. The firm's performance qualification for a packaging machine was found inadequate, as container closure integrity at higher pressures was not demonstrated, potentially compromising vial integrity. Additionally, in-process control testing for drug products utilized insufficient sample sizes, raising concerns about batch consistency and overall product integrity.
ID · f42eaa83-6c51-4d59-9e00-368135ec25aa